Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albendazole in HIV-Positive Patients With Intestinal Microsporidiosis
NCT00002191Phase 3Completed
- Sponsor
- GSK
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of albendazole in Intestinal Microsporidiosis, sponsored by GSK. Status: completed.
02
Drugs
albendazole
03
Conditions
Intestinal Microsporidiosis
Beyond the preview
Go deeper on NCT00002191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002191.